Progression to left ventricular dilatation in patients with hypertrophic obstructive cardiomyopathy

Insights

Hypertrophic obstructive cardiomyopathy can progress to congestive heart failure with a dilated left ventricle, even after surgery. This study highlights left ventricular dilatation as a potential complication in these patients.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Heart Failure Research

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) is a condition characterized by thickening of the heart muscle, leading to outflow obstruction.
  • Surgical interventions are often employed to alleviate the obstruction in symptomatic HOCM patients.
  • The long-term structural and functional consequences of HOCM and its surgical treatment require further investigation.

Observation:

  • Two patients with symptomatic HOCM who underwent prior cardiac surgery developed congestive heart failure.
  • Echocardiography revealed significant alterations in left ventricular structure and function during the heart failure episode.
  • These echocardiographic changes persisted or evolved following the acute failure event.

Findings:

  • The development of congestive heart failure with a dilated left ventricle was observed in patients with previously treated HOCM.
  • Left ventricular dilatation emerged as a potential adverse outcome in the studied HOCM cohort.
  • Structural and functional remodeling of the left ventricle may occur in the progression of HOCM.

Implications:

  • Left ventricular dilatation should be considered a potential complication in the management of hypertrophic obstructive cardiomyopathy.
  • Long-term echocardiographic monitoring is crucial for identifying and managing ventricular remodeling in HOCM patients.
  • These findings may inform clinical guidelines and surgical strategies for hypertrophic obstructive cardiomyopathy to mitigate risks of heart failure progression.

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...